Univest
Univest
  • Markets

Sudarshan Pharma Industries (SUDARSHAN) Share Price rises 8.11% today

  • October 9, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments
Sudarshan Pharma Industries Share Price
Sudarshan Pharma Industries Ltd. (SUDARSHAN) share price rose to Rs 38 today, up 8.11% from the previous close. Market cap was Rs 990.15 crore.

Sudarshan Pharma Industries Share Price is trading at Rs 38, up 8.11% on the day, with market capitalisation at Rs 990.15 crore. Univest figures confirm the price action, but they do not point to a specific company trigger. The move places Sudarshan Pharma Industries Share Price in focus as a top gainer today within broader Share Market Today moves, but the verified facts stay limited to price action and the company’s reported fundamentals. For readers tracking Sudarshan Pharma Industries Share Price Today, the key context is straightforward: the stock moved above its previous close of Rs 35.15 and is trading near the upper end of the day’s range. Univest analysis shows that the next useful check is whether the valuation, sector comparison and peer position support the move in current Market News.

Table of Contents

Toggle
  • Sudarshan Pharma Industries Share Price Today: Price Action Analysis
  • Sudarshan Pharma Industries Ltd. (SUDARSHAN) Fundamental Analysis
  • Sector and Industry Context
  • Peer Comparison
  • Why Investors Are Watching Sudarshan Pharma Industries
  • About Sudarshan Pharma Industries
  • Frequently Asked Questions
    • What is Sudarshan Pharma Industries Share Price today?
    • Why is Sudarshan Pharma Industries Share Price rising today?
    • What was the previous close for Sudarshan Pharma Industries Share Price?
    • How much did Sudarshan Pharma Industries Share Price gain today?
    • What is the market cap of Sudarshan Pharma Industries?
    • Is Sudarshan Pharma Industries Share Price expensive on valuation?
    • How do ROE and ROCE look for Sudarshan Pharma Industries?
    • How does Sudarshan Pharma Industries compare with peers?
  • Track Sudarshan Pharma Industries Share Price on Univest

Sudarshan Pharma Industries Share Price Today: Price Action Analysis

Metric Value
Current Price Rs 38
Previous Close Rs 35.15
Today's Move Rs 2.85 (+8.11%)
Open Rs 36.18
High Rs 38.66
Low Rs 34.29
Market Capitalisation Rs 990.15 crore
Market Cap Category Micro Cap

Sudarshan Pharma Industries Ltd. (SUDARSHAN) rose to Rs 38 from the previous close of Rs 35.15, a move of Rs 2.85 or 8.11%. The stock opened at Rs 36.18, reached a high of Rs 38.66, recorded a low of Rs 34.29.

Sudarshan Pharma Industries Share Price is higher today by Rs 2.85, or 8.11%, with the stock last traded at Rs 38. The move came after an open of Rs 36.18 and was accompanied by a day range between Rs 34.29 and Rs 38.66. The previous close was Rs 35.15, so the current print shows a clear intraday share price gain without needing any further explanation from unverified factors. For investors watching Sudarshan Pharma Industries Share Price Live, the immediate point is the price position relative to the day’s range and the current market capitalisation of Rs 990.15 crore. This is the core Price Action reading in today’s Indian Stock Market move. Univest data keeps the interpretation narrow: the price event is confirmed, while the reason remains unconfirmed. That makes Sudarshan Pharma Industries Share Price Today a factual stock news update rather than a catalyst-led story.

Sudarshan Pharma Industries Ltd. (SUDARSHAN) Fundamental Analysis

Metric Value
Market Capitalisation Rs 990.15 crore
P/E Ratio 35.6x
P/B Ratio 2.73x
ROE 13.33%
ROCE 14.42%
EPS Rs 0.99
Book Value Per Share Rs 12.89
Dividend Yield 0%

Sudarshan Pharma Industries Ltd. (SUDARSHAN) fundamental metrics show P/E 35.6x, P/B 2.73x, ROE 13.33%, ROCE 14.42%. Taken on their own, these numbers offer context rather than a trading signal.

Sudarshan Pharma Industries Ltd. has a market capitalisation of Rs 990.15 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 35.6x, P/B at 2.73x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 13.33% and ROCE of 14.42%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 0.99, book value per share of Rs 12.89, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.28x, median ROE of 11.61%, median ROCE of 13.46%. They set out the fundamental picture and are not a rating on the stock.

Sector and Industry Context

Metric Value
Sector Healthcare
Industry Pharmaceuticals & Drugs
Benchmark Scope same industry
Company P/E Ratio 35.6x
Benchmark Median P/E 31.28x
Benchmark Average P/E 47.09x
Benchmark P/E Range 3.56x to 678.22x
Company P/B Ratio 2.73x
Benchmark Median P/B 2.85x
Company ROE 13.33%
Benchmark Median ROE 11.61%
Company ROCE 14.42%
Benchmark Median ROCE 13.46%
Company Market Capitalisation Rs 990.15 crore
Benchmark Median Market Cap Rs 821.44 crore

Sudarshan Pharma Industries Ltd. (SUDARSHAN) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.

Sudarshan Pharma Industries Ltd. (SUDARSHAN) has a P/E ratio of 35.6x, which is above the benchmark median of 31.28x, a difference of +13.81%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Sudarshan Pharma Industries Ltd. (SUDARSHAN) has a ROE of 13.33%, which is above the benchmark median of 11.61%, a difference of +14.81%. Sudarshan Pharma Industries Ltd. (SUDARSHAN) has a ROCE of 14.42%, which is above the benchmark median of 13.46%, a difference of +7.13%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company Symbol Market Cap (Cr) P/E P/B ROE (%) ROCE (%)
Sun Pharmaceutical Industries Ltd. SUNPHARMA 4,27,861.41 34.76 4.86 14.85 19.11
Divi's Laboratories Ltd. DIVISLAB 2,54,318.9 85.21 14.11 16.19 21.51
Torrent Pharmaceuticals Ltd. TORNTPHARM 1,79,153.26 81.53 19.81 26.76 19.27
Zydus Lifesciences Ltd. ZYDUSLIFE 1,15,111.94 24.65 4.13 19.69 21.39
Laurus Labs Ltd. LAURUSLABS 1,11,034.16 98.83 19.16 18.31 18.2

Sudarshan Pharma Industries Ltd. (SUDARSHAN) has a P/E ratio of 35.6x compared with the displayed peer median of 81.53x. The comparison is relative and should not be read as a recommendation. Its ROE of 13.33% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 14.42% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Sudarshan Pharma Industries Ltd. (SUDARSHAN) has a market capitalisation of Rs 990.15 crore. All 5 peers shown have a larger market capitalisation.

Why Investors Are Watching Sudarshan Pharma Industries

  • Sudarshan Pharma Industries Share Price is up 8.11% today, with the stock last traded at Rs 38.
  • The day’s range of Rs 34.29 to Rs 38.66 gives a clear snapshot of current Price Action.
  • Market capitalisation stands at Rs 990.15 crore, which Univest places against the same-industry benchmark.
  • P/E of 35.6 and P/B of 2.73 give Sudarshan Pharma Industries Share Price a defined valuation profile.
  • ROE of 13.33% and ROCE of 14.42% provide the main fundamental context for today’s stock news.

About Sudarshan Pharma Industries

Sudarshan Pharma Industries Ltd. operates in the Pharmaceuticals & Drugs industry under the Healthcare sector. The company’s stock profile on Univest places Sudarshan Pharma Industries Share Price within a market where valuation, earnings efficiency and book value matter for comparison across peers. The reported figures point to a business being assessed through its share price, market cap, earnings per share, book value and return ratios rather than through any single day’s move. Sudarshan Pharma Industries Share Price Today therefore belongs in a broader company overview that includes fundamental analysis and sector analysis together. The company’s reported market capitalisation of Rs 990.15 crore, EPS of Rs 0.99 and book value of Rs 12.89 help form the baseline for that overview. For investors scanning Sudarshan Pharma Industries Share News or Sudarshan Pharma Industries Company News, the most useful lens is to connect the day’s price rise with the company’s relative position in its industry and its valuation versus peers.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).

Frequently Asked Questions

What is Sudarshan Pharma Industries Share Price today?

Ans. Sudarshan Pharma Industries Share Price is Rs 38 today, up 8.11% from the previous close of Rs 35.15. The move has placed the stock in today’s market focus, with market capitalisation at Rs 990.15 crore.

Why is Sudarshan Pharma Industries Share Price rising today?

Ans. Univest figures confirm the price action, but they do not point to a specific company trigger. Sudarshan Pharma Industries Share Price is higher by Rs 2.85, and the verified facts do not identify a separate reason.

What was the previous close for Sudarshan Pharma Industries Share Price?

Ans. The previous close for Sudarshan Pharma Industries Share Price was Rs 35.15. The stock opened at Rs 36.18 and later traded between Rs 34.29 and Rs 38.66 during the day.

How much did Sudarshan Pharma Industries Share Price gain today?

Ans. Sudarshan Pharma Industries Share Price gained Rs 2.85, which equals 8.11% for the day. That puts the stock above its previous close and near the upper end of its intraday range.

What is the market cap of Sudarshan Pharma Industries?

Ans. Sudarshan Pharma Industries has a market capitalisation of Rs 990.15 crore. In the same-industry benchmark, that is above the median market cap of Rs 821.44 crore, though below the average.

Is Sudarshan Pharma Industries Share Price expensive on valuation?

Ans. Sudarshan Pharma Industries Share Price trades at 35.6 times earnings and 2.73 times book. That is above the industry median P/E of 31.28 but below the benchmark average of 47.09.

How do ROE and ROCE look for Sudarshan Pharma Industries?

Ans. ROE stands at 13.33% and ROCE at 14.42%. Both are above the industry medians of 11.61% and 13.46%, which adds context to Sudarshan Pharma Industries Share Price from a return-ratio angle.

How does Sudarshan Pharma Industries compare with peers?

Ans. Sudarshan Pharma Industries Share Price has a smaller market cap than Sun Pharma, Divi's Laboratories, Torrent Pharmaceuticals, Zydus Lifesciences and Laurus Labs. Its valuation sits below several richer peers but above some others.

Track Sudarshan Pharma Industries Share Price on Univest

Use Sudarshan Pharma Industries Ltd. (SUDARSHAN) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Univest lets readers follow Sudarshan Pharma Industries Share Price alongside live share price movement, valuation ratios, 52-week levels and broader market insights. For anyone revisiting Sudarshan Pharma Industries Stock News or Sudarshan Pharma Industries Latest News, the same page can also help connect price action with fundamental ratios and industry context. Sudarshan Pharma Industries Share Price Today is best followed as a combined view of price, valuation and sector placement, not as an isolated intraday print. Univest keeps that structure simple for readers who want one place to monitor the stock’s Share Price, market cap and key ratios over time.



Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply